Further, we also found that MDA-7/IL-24 mounted an antitumor immune response by increasing levels of infiltrating CD8+ T cells and the frequency of IFN-γ or granzyme B-producing CD8+ T cells in the mammary tumors. This evidence concerns the gene CD8A and breast cancer.